Status:

UNKNOWN

Multicomponent Therapy With Telerehabilitation

Lead Sponsor:

Istanbul University

Conditions:

Fibromyalgia

Eligibility:

FEMALE

18-55 years

Phase:

NA

Brief Summary

In this prospective, randomized study, our aim was to evaluate the comprehensive multicomponent treatment of fibromyalgia women with telerehabilitation, including "patient education, special psychothe...

Detailed Description

Patients who meet the inclusion criteria will be randomized into two groups by computer program after being numbered according to the order of application. 33 patients in the multicomponent treatment ...

Eligibility Criteria

Inclusion

  • Women
  • Symptom persistence for more than 3 months
  • Pervasive Network Scale Score \>7 and Symptom Severity Score \>5 according to 2016 ACR criteria
  • Symptom Severity Score of \>9 and Diffuse Pain Scale Score between 4-6 according to 2016 ACR criteria
  • Getting a high (11 and above) score on the Hospital Anxiety and Depression Scale
  • Having the opportunity to participate in the applications online
  • No change in the medical treatment he received for fibromyalgia syndrome during the study period
  • Those between the ages of 18-55

Exclusion

  • Patients with endocrine, neuromuscular, infectious and inflammatory rheumatological diseases
  • Patients with liver or kidney disease
  • Patients with malignancy
  • Patients with a history of severe trauma
  • Patients with severe psychiatric illness
  • Patients with serious physical comorbidities
  • The illiterate
  • Known central nervous system or peripheral nervous system disease, progressive neurological deficit
  • Peripheral venous insufficiency, coagulopathies and anticoagulant drug use
  • Serious cardiovascular pathologies
  • Loss of sensation, loss of position sense, unhealed fracture or open surgical wound
  • Pregnancy

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT05250531

Start Date

March 1 2022

End Date

December 1 2022

Last Update

February 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation

Istanbul, Fatih, Turkey (Türkiye), 34093